Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, October 23, 2020

Metformin Use Tied to Slower Cognitive Decline, Less Dementia Risk

 

You are already in a cognitive hole from your stroke, what is your doctor's EXACT PROTOCOL for cognitive recovery?  Don't let your doctor

DO NOTHING, dig a deeper hole and leave you down there.

You lost 5 cognitive years from the stroke.

Metformin Use Tied to Slower Cognitive Decline, Less Dementia Risk

 

-New study adds evidence for T2D drug's mental benefits

by Contributing Writer, MedPage Today

Study Authors: Katherine Samaras, Steve Makkar, et al.

Target Audience and Goal Statement: Endocrinologists, geriatricians, primary care physicians, psychiatrists

The goals of this study were to determine the associations between metformin use and levels of cognitive decline and incident dementia over 6 years in older people with type 2 diabetes, and to compare these effects with those in patients with diabetes not receiving metformin and older people without diabetes.

Question Addressed:

  • Did use of metformin slow cognitive decline and reduce the risk of dementia in older patients with type 2 diabetes?

Study Synopsis and Perspective:

Cognitive dysfunction has been recognized as an important comorbidity of diabetes, which affects an estimated 18% of people older than 65 worldwide. Comorbid diabetes and cognitive dysfunction affect an estimated 13% of people ages 65-74 and 24% of those age 75 and older, according to an analysis of a U.S. veterans registry.

Action Points

  • Use of metformin was linked with slower cognitive decline and reduced risk of dementia in older patients with type 2 diabetes, according to a prospective observational study.
  • Note that the rate of decline in global cognition was significantly slower in patients with diabetes treated with metformin compared with those treated with other therapies and was similar to that of patients without diabetes.
Posted by at
Labels: , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)